Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Opinions/ J3 outcome almost a moot point

Opinions/ J3 outcome almost a moot point

posted on Jun 23, 2006 06:50PM
Just got home from a grueling 18 hour day at the auction..........This news sure made me feel younger.......

As i posted before MANY people figured that we would not see any settlements until the J3 case was concluded..........We now see that the J3 Texas case has no impact on these CO`S from buying the IP........

THIS IS NOT A PUMP, but imo the evidence/signed deals tells us more will be on the way and no matter what the J3 decides to do we really have co`s waiting in the wings............The J3 can be iceing on the cake but i like my cake with or without iceing..............I am amazed at out low SP BUT i believe that we all know in the future we will be going up several floors.........Good night and have a great weekend......I look forward to attending the SHM........Larry

Share
New Message
Please login to post a reply